Home Search Contacts Help
ABPI - The Association of the British Pharmaceutical Industry
 
ABPI Annual Review 2003

ABPI Board of Management
  
Dr John Patterson Prof Trevor M Jones Olivier Brandicourt David Brickwood Chris Brinsmead Nigel Brooksby
Dr John Patterson
AstraZeneca
President		 Prof Trevor M Jones
 CBE ABPI		 Olivier Brandicourt
Pfizer		 David Brickwood
Johnson & Johnson		 Chris Brinsmead
AstraZeneca		 Nigel Brooksby
Sanofi Synthélabo
Pierre Chancel Dr David Glover Eddie Gray Keith Hemming David Hill Dr Paul Hooper
Pierre Chancel
Aventis Pharma		 Dr David Glover
 Cambridge Antibody Technology Group		 Eddie Gray
 GlaxoSmithKline		 Keith Hemming
 Fujisawa		 David Hill
 Leo Pharmaceuticals

Dr Paul Hooper
 Eisai

 
Kevin James Chrissie Kimmons Prof Vincent Lawton John Melville Drummond Paris Mike Wallace
Kevin James
 Wyeth		 Chrissie Kimmons
 Consultant		 Prof Vincent Lawton
 Merck Sharp & Dohme		 John Melville
 Roche Products		 Drummond Paris
 Novartis

Mike Wallace
 Schering Health Care

The directors of the ABPI and related organisations

Professor
Trevor Jones
Director General
Michael Mitchell
Director of Finance
Andrew Curl Deputy Director General Dr Richard Tiner Director of Medical Affairs
Martin Anderson Director of Commercial Affairs Dr Philip Wright Director of Science and Technology
Jim Eadie Director, Scotland Professor
Adrian Towse		 Director of the Office of Health Economics
Dr Rick Greville Director, Wales Heather Simmonds Director of the Prescription Medicines Code of Practice Authority
Ben Hayes Director of Public Affairs    
Alan Hunter Secretary of the Association and Director of Law and Intellectual Property    

 

 
 
Previous Page | Print Page | Top of Page
Copyright © ABPI - The Association of the British Pharmaceutical Industry Terms and Conditions | Privacy Policy